
Client Alert
23/08/2023
ANVISA promotes changes in the Regulatory Framework for medical devices that aim to bring legal certainty to importers
The advent of RDC 751/2022 was important for the medical devices sector, as it updated Brazil’s regulatory framework after 2 (two) decades of validity. However, despite all the discussion that headed its publication, the Brazilian Health Regulatory Agency (Anvisa) needed to update it quickly to bring more legal certainty to the regulated sector, as well as to …





